Document Detail

Refractory no-reflow successfully treated with local infusion of high-dose adenosine and verapamil--a case report.
MedLine Citation:
PMID:  11228087     Owner:  NLM     Status:  MEDLINE    
No-reflow is an unpredictable complication following percutaneous coronary intervention. No-reflow is associated with myocardial ischemia and infarction and increased mortality. A case of refractory no-reflow is described that was rapidly and successfully treated with multiple infusions of high doses of verapamil and adenosine applied directly at the site of no-reflow through a perfusion catheter.
W C Dillon; D Hadian; M E Ritchie
Related Documents :
23214367 - Heart rate turbulence in mild-to-moderate aortic stenosis in boxers.
17694377 - Multi-vessel stenting during primary percutaneous coronary intervention for acute myoca...
23350927 - Predicting functional capacity in patients with a systemic right ventricle: subjective ...
20129567 - 3-dimensional bifurcation angle analysis in patients with left main disease: a substudy...
7543727 - Stenosis severity and the occurrence of ventricular ectopic activity during acute coron...
19167637 - Important parameters in the detection of left main trunk disease using stress myocardia...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Angiology     Volume:  52     ISSN:  0003-3197     ISO Abbreviation:  Angiology     Publication Date:  2001 Feb 
Date Detail:
Created Date:  2001-02-28     Completed Date:  2001-03-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0203706     Medline TA:  Angiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  137-41     Citation Subset:  IM    
Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis 46202, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenosine / administration & dosage*,  therapeutic use
Angioplasty, Transluminal, Percutaneous Coronary
Coronary Angiography
Coronary Circulation
Coronary Disease / drug therapy,  therapy*
Heart Catheterization
Infusions, Intra-Arterial
Middle Aged
Vasodilator Agents / administration & dosage*,  therapeutic use
Verapamil / administration & dosage*,  therapeutic use
Reg. No./Substance:
0/Vasodilator Agents; 52-53-9/Verapamil; 58-61-7/Adenosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison between isosorbide dinitrate in aerosol and in tablets for the treatment of hypertensive ...
Next Document:  Exercise-induced left bundle branch block during thallium 201 myocardial perfusion scintigraphy--a c...